Niue vs Southern Asia: Proportion of the target population who received a 3rd dose of
Niue
99.0%
in 2024
Southern Asia
88.0%
in 2024
Niue rank
1st
Southern Asia rank
4th
Proportion of the target population who received a 3rd dose of over time
- Niue
- Southern Asia
How they compare
Niue currently reports 99.0% against 88.0% in Southern Asia, a difference of 11.0%.
That makes Niue's figure about 1.1 times Southern Asia's.
Across all 12 years both countries report, Niue has been ahead every year.
Niue ranks 1st and Southern Asia ranks 4th of 157 countries.
Niue has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niue | Southern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 99.0% | 22.9% | 76.1% | Niue |
| 2020s | 99.0% | 64.2% | 34.8% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Niue or Southern Asia?
- Niue, at 99.0% against 88.0% in Southern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Niue and Southern Asia?
- 11.0%, with Niue ahead.
- How many years of comparable data are there for Niue and Southern Asia?
- 12 years are reported by both, from 2013 to 2024.
- How do Niue and Southern Asia rank globally for proportion of the target population who received a 3rd dose of?
- Niue ranks 1st and Southern Asia ranks 4th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.